FLGT
Price
$22.75
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
47 days until earnings call
NEO
Price
$16.29
Change
-$0.00 (-0.00%)
Updated
Sep 17 closing price
41 days until earnings call
Ad is loading...

FLGT vs NEO

Header iconFLGT vs NEO Comparison
Open Charts FLGT vs NEOBanner chart's image
Fulgent Genetics
Price$22.75
Change-$0.00 (-0.00%)
Volume$153.31K
CapitalizationN/A
NeoGenomics
Price$16.29
Change-$0.00 (-0.00%)
Volume$555.04K
CapitalizationN/A
View a ticker or compare two or three
FLGT vs NEO Comparison Chart
Loading...
FLGT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NEO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
FLGT vs. NEO commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FLGT is a Buy and NEO is a StrongSell.

COMPARISON
Comparison
Sep 19, 2024
Stock price -- (FLGT: $22.75 vs. NEO: $16.29)
Brand notoriety: FLGT and NEO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: FLGT: 90% vs. NEO: 68%
Market capitalization -- FLGT: $648.84M vs. NEO: $2.01B
FLGT [@Medical Specialties] is valued at $648.84M. NEO’s [@Medical Specialties] market capitalization is $2.01B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.86B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FLGT’s FA Score shows that 1 FA rating(s) are green whileNEO’s FA Score has 0 green FA rating(s).

  • FLGT’s FA Score: 1 green, 4 red.
  • NEO’s FA Score: 0 green, 5 red.
According to our system of comparison, FLGT is a better buy in the long-term than NEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FLGT’s TA Score shows that 5 TA indicator(s) are bullish while NEO’s TA Score has 5 bullish TA indicator(s).

  • FLGT’s TA Score: 5 bullish, 4 bearish.
  • NEO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, FLGT is a better buy in the short-term than NEO.

Price Growth

FLGT (@Medical Specialties) experienced а +5.32% price change this week, while NEO (@Medical Specialties) price change was +4.29% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.43%. For the same industry, the average monthly price growth was +0.16%, and the average quarterly price growth was -3.16%.

Reported Earning Dates

FLGT is expected to report earnings on Nov 04, 2024.

NEO is expected to report earnings on Oct 29, 2024.

Industries' Descriptions

@Medical Specialties (+1.43% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NEO($2.01B) has a higher market cap than FLGT($649M). NEO has higher P/E ratio than FLGT: NEO (49.50) vs FLGT (7.33). NEO YTD gains are higher at: 0.680 vs. FLGT (-21.308). NEO has higher annual earnings (EBITDA): -17.61M vs. FLGT (-49.15M). FLGT (424M) and NEO (415M) have equal amount of cash in the bank . FLGT has less debt than NEO: FLGT (15.3M) vs NEO (612M). NEO has higher revenues than FLGT: NEO (592M) vs FLGT (289M).
FLGTNEOFLGT / NEO
Capitalization649M2.01B32%
EBITDA-49.15M-17.61M279%
Gain YTD-21.3080.680-3,134%
P/E Ratio7.3349.5015%
Revenue289M592M49%
Total Cash424M415M102%
Total Debt15.3M612M3%
FUNDAMENTALS RATINGS
FLGT vs NEO: Fundamental Ratings
FLGT
NEO
OUTLOOK RATING
1..100
865
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
67
Overvalued
PROFIT vs RISK RATING
1..100
90100
SMR RATING
1..100
9493
PRICE GROWTH RATING
1..100
5945
P/E GROWTH RATING
1..100
10100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FLGT's Valuation (50) in the Medical Or Nursing Services industry is in the same range as NEO (67). This means that FLGT’s stock grew similarly to NEO’s over the last 12 months.

FLGT's Profit vs Risk Rating (90) in the Medical Or Nursing Services industry is in the same range as NEO (100). This means that FLGT’s stock grew similarly to NEO’s over the last 12 months.

NEO's SMR Rating (93) in the Medical Or Nursing Services industry is in the same range as FLGT (94). This means that NEO’s stock grew similarly to FLGT’s over the last 12 months.

NEO's Price Growth Rating (45) in the Medical Or Nursing Services industry is in the same range as FLGT (59). This means that NEO’s stock grew similarly to FLGT’s over the last 12 months.

FLGT's P/E Growth Rating (10) in the Medical Or Nursing Services industry is significantly better than the same rating for NEO (100). This means that FLGT’s stock grew significantly faster than NEO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FLGTNEO
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
71%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 7 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 6 days ago
79%
Bullish Trend 8 days ago
79%
Declines
ODDS (%)
Bearish Trend 10 days ago
82%
Bearish Trend 2 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
74%
View a ticker or compare two or three
Ad is loading...
FLGT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NEO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BUIOX16.830.10
+0.60%
Buffalo Early Stage Growth Instl
JUESX25.410.05
+0.20%
JPMorgan US Equity I
GCECX17.160.01
+0.06%
AB Global Core Equity C
VLAAX45.76-0.20
-0.44%
Value Line Asset Allocation Investor
JAREX14.90-0.10
-0.67%
Easterly Global Real Estate A

FLGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, FLGT has been loosely correlated with CERS. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if FLGT jumps, then CERS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FLGT
1D Price
Change %
FLGT100%
+2.94%
CERS - FLGT
51%
Loosely correlated
-4.37%
VCYT - FLGT
47%
Loosely correlated
+2.05%
NVST - FLGT
46%
Loosely correlated
+0.58%
NEO - FLGT
45%
Loosely correlated
-0.24%
MMSI - FLGT
44%
Loosely correlated
-1.13%
More